ALTIMMUNE, INC. Total Assets
ALTIMMUNE, INC. (ALT) had Total Assets of $527.21 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-12
- 2026-06-30: Assets $527.21M.
- 2026-03-31: Assets $335.63M.
- 2025-12-31: Assets $279.93M.
- 2025-09-30: Assets $218.45M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $527.21M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $335.63M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $279.93M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $218.45M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $190.35M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $157.26M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $139.31M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $147.86M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $173.35M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $188.36M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $210.64M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $166.57M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $183.32M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $187.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $206.93M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $225.28M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $209.91M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $205.66M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $218.87M 10-K · filed 2023-02-28 | $218.86M 10-K · filed 2022-03-15 |
| 2021-09-30 | $236.91M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $257.26M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $264.25M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $245.12M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $233.00M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $102.54M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $54.23M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $54.06M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $56.39M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $61.98M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $65.37M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $54.75M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $52.86M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $52.10M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $60.87M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $63.03M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $74.35M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $90.84M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $20.73M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $38.40M 10-K · filed 2018-04-02 | $224.74M 10-K · filed 2017-03-14 |
| 2016-09-30 | $140.54M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $27.93M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $18.73M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $19.86M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $20.90M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $22.62M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $25.47M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $21.98M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $23.35M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $15.22M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $14.37M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $17.14M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $20.62M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $24.59M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $21.97M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $22.74M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $23.41M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $23.81M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $24.75M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $22.80M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $21.64M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $26.32M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $27.20M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |